Latest Breaking News On - News ratings for corvus pharmaceuticals daily - Page 1 : comparemela.com

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Pass Above 50 Day Moving Average of $1 77

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Pass Above 50 Day Moving Average of $1 77
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

William benton jonesInsider transactions at corvus pharmaceuticalsCantor fitzgeraldInstitutional trading of corvus pharmaceuticalsNews ratings for corvus pharmaceuticals dailyCorvus pharmaceuticalsCorvus pharmaceuticals stockSecurities exchange commissionCorvus pharmaceuticals incVanguard group incGet free reportFree reportCorvus pharmaceuticals daily

Insider Buying: Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) Insider Buys $34,600 00 in Stock

Insider Buying: Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) Insider Buys $34,600 00 in Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

William benton jonesSecurities exchange commissionCorvus pharmaceuticals stockCorvus pharmaceuticals company profileCorvus pharmaceuticals incHedge funds weigh in on corvus pharmaceuticalsCantor fitzgeraldCorvus pharmaceuticalsNews ratings for corvus pharmaceuticals dailyGet free reportFree reportCorvus pharmaceuticals daily

William Benton Jones Purchases 20,000 Shares of Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) Stock

William Benton Jones Purchases 20,000 Shares of Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William benton jonesCantor fitzgeraldExchange commissionNews ratings for corvus pharmaceuticals dailyCorvus pharmaceuticals trading downInstitutional trading of corvus pharmaceuticalsCorvus pharmaceuticals incCorvus pharmaceuticalsSecurities exchange commissionGet free reportPharmaceuticals trading downFree reportCorvus pharmaceuticals daily

Corvus Pharmaceuticals (CRVS) Set to Announce Earnings on Monday

Corvus Pharmaceuticals (CRVS) Set to Announce Earnings on Monday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

News ratings for corvus pharmaceuticals dailyCorvus pharmaceuticals company profileEarnings history for corvus pharmaceuticalsCorvus pharmaceuticalsCantor fitzgeraldCorvus pharmaceuticals incCorvus pharmaceuticals stock performanceGet free reportCorvus pharmaceuticals daily

Towerview LLC Boosts Stock Position in Corvus Pharmaceuticals, Inc (NASDAQ:CRVS)

Towerview LLC grew its holdings in shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 27.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 436,873 shares of the company’s stock after buying an additional 94,395 shares during the quarter. […]

United statesTower research capitalCorvus pharmaceuticals incRenaissance technologiesCantor fitzgeraldExchange commissionCorvus pharmaceuticalsNews ratings for corvus pharmaceuticals dailyAmerican century companies incCorvus pharmaceuticals stock performanceQuarter for corvus pharmaceuticalsCharles schwab investment management incFree reportResearch capitalStreet corpSchwab investment management